Picard Medical, Inc. (PMI) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Picard Medical, Inc. on April 13, 2026, reporting events occurring on April 7, 2026. The Company, an emerging growth company incorporated in Delaware, entered into a material definitive agreement to secure short-term financing.
Key Financial Metrics and Transaction Details
The filing details a financing transaction rather than periodic financial performance metrics. Key terms include:
- Instrument: Convertible Promissory Note and Origination Shares.
- Principal Face Amount: $555,555.56.
- Net Proceeds: $490,000.00 (after a $55,555.56 original issue discount and $10,000 in withheld expenses).
- Equity Issued: 80,128 shares of Common Stock as origination shares.
- Interest: One-time charge of 12% ($66,666.67) applied at issuance.
- Repayment Schedule: Six equal monthly installments of $103,703.70, commencing July 1, 2026, through December 1, 2026.
- Maturity: Nine months from the issue date.
Material Changes and Terms
The transaction introduces a new direct financial obligation and potential equity dilution. Material terms include:
- Default Provisions: Upon an Event of Default, the interest rate increases to the lesser of 20% or the maximum legal rate. The note becomes immediately due at 150% of the outstanding principal, subject to a cumulative maximum of 200%.
- Conversion Rights: Only upon an Event of Default may the Buyer convert the principal and interest into Common Stock at 75% of the lowest trading price of the prior 10 trading days, subject to a 4.99% beneficial ownership limitation.
- Covenants: The Company is restricted from paying dividends or making other distributions on capital stock without the Buyer's written consent while the Note is outstanding.
Outlook, Risks, and Contingencies
The filing does not provide forward-looking guidance, management commentary on future operations, or specific risk factors beyond the terms of the Note. The primary contingency is the risk of an Event of Default, which would trigger accelerated repayment obligations and significant equity dilution via the conversion feature. The securities were issued unregistered under Section 4(a)(2) and Regulation D exemptions.
Investor Verification Checklist
- Verify the Company's current cash position to assess the ability to meet the first repayment installment of $103,703.70 due July 1, 2026.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) and Convertible Promissory Note (Exhibit 4.1) for specific definitions of "Event of Default."
- Monitor the trading price of PMI Common Stock to understand the potential dilution impact if a default triggers the 75% conversion discount.
- Confirm whether the $490,000 net proceeds are sufficient to cover immediate operational needs given the high cost of capital (12% upfront interest).